HLS Therapeutics Inc's market cap is currently C$177.04M. The company's EPS TTM is C$-0.1248926274; its P/E ratio is ―; HLS Therapeutics Inc is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is C$-0.09. See an overview of income statement, balance sheet, and cash flow financials.
